M. Versola
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 8
-
- Lung Cancer Treatments and Mutations 9
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Kevin M. Koch (14 shared papers)Deborah A. Smith (10 shared papers)Lini Pandite (8 shared papers)Ronald A. Fleming (3 shared papers)Suzanne F. Jones (5 shared papers)Neil L. Spector (6 shared papers)Andrew G. Stead (6 shared papers)Howard A. Burris (3 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)Cancer Investigation (1 paper)European Journal of Cancer Supplements (4 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
M. Versola
22 papers receiving 448 citations
Peers
Comparison fields: 5 of 45
- Oncology 305
- Genetics 54
- Hematology 47
- Pulmonary and Respiratory Medicine 124
- Hepatology 19
Countries citing papers authored by M. Versola
This map shows the geographic impact of M. Versola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Versola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Versola more than expected).
Fields of papers citing papers by M. Versola
This network shows the impact of papers produced by M. Versola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Versola. The network helps show where M. Versola may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Versola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 85 | |
| 2 | 2007 | 49 | |
| 3 | 2007 | 43 | |
| 4 | 2007 | 41 | |
| 5 | 2004 | 38 | |
| 6 | 2004 | 30 | |
| 7 | 2004 | 22 | |
| 8 | 2013 | 20 | |
| 9 | 2004 | 20 | |
| 10 | 2004 | 15 | |
| 11 | 2004 | 14 | |
| 12 | 2004 | 13 | |
| 13 | 2005 | 12 | |
| 14 | 2003 | 11 | |
| 15 | 2004 | 11 | |
| 16 | 2004 | 9 | |
| 17 | 2004 | 7 | |
| 18 | 2003 | 6 | |
| 19 | 2003 | 5 | |
| 20 | 2004 | 4 |
About M. Versola
M. Versola is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Cell Biology and Genetics, having authored 22 papers that have together received 459 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (8 papers), Microtubule and mitosis dynamics (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Oncology (305 citations), Genetics (54 citations), Hematology (47 citations), Pulmonary and Respiratory Medicine (124 citations) and Hepatology (19 citations). M. Versola has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Kevin M. Koch, Deborah A. Smith, Lini Pandite, Ronald A. Fleming, Suzanne F. Jones, Neil L. Spector, Andrew G. Stead, Howard A. Burris, H. A. Burris and Niki Arya. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Cancer Investigation and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.